We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bipartisan Senators Seek Answers on Gilead's Expensive Hep C Drug Sovaldi
Bipartisan Senators Seek Answers on Gilead's Expensive Hep C Drug Sovaldi
The price of Gilead’s hepatitis C drug Sovaldi once again is drawing bipartisan fire from Capitol Hill, this time from two senators who are demanding answers as to how the company arrived at the product’s $1,000-a-pill price tag.